361 results
Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation
15 Mar 2021
The aim of this study was to investigate the prognostic value of thermodilution-derived coronary flow capacity (T-CFC) in patients with stable coronary artery disease and deferred revascularisation.
Authors :
3-year outcomes of the ULTIMATE trial comparing intravascular ultrasound versus angiography-guided drug-eluting stent implantation
23 Feb 2021
ULTIMATE provides additional long-term randomised control data showing the benefit of IVUS guided PCI in an all-comers population.
Reviewer
Mortality 10 years after percutaneous or surgical revascularization in patients with total coronary artery occlusions
16 Feb 2021
The proposed manuscript is an intriguing sub-analysis from the recent SYNTAX Extended Survival (SYNTAXES) study, where the Synergy Between PCI With Taxus and Cardiac Surgery (SYNTAX) was investigated.
Reviewer
Reviewer
Death and myocardial infarction following initial revascularization vs optimal medical therapy in chronic coronary syndromes with myocardial ischemia
16 Feb 2021
A systematic review and meta-analysis of contemporary randomized controlled trials published in the JAHA, interpreted using a standardized two-step approach: PICOT and SWOT
What you need to know about DAPT in high-bleeding risk patients
12 Dec 2020 – From GulfPCR-GIM 2020
This educational session focuses on the high-bleeding risk situation in the Gulf Region, the latest evidence on HBR and how to integrate it into your practice, followed by challenging cases discussed by Mirvat Alasnag,Thomas Cuisset, Marco Valgimigli and Peter Smits.
CAD management in TAVI patients
12 Dec 2020 – From GulfPCR-GIM 2020
Watch this session if you want to reflect on optimal management of CAD in TAVI candidates, to discuss tips and tricks to improve future coronary access during TAVI procedure and to review how to optimise management of CAD in post-TAVI patients.
This session was originally presented during...
The year in review in Interventional Cardiology: clinical trials and relevant literature published in 2020
12 Dec 2020 – From GulfPCR-GIM 2020
Watch this session if you want to reflect on key learnings for clinical practice from selected trials published in 2020, to get a rapid overview of the most relevant literature of the year in the fields of coronary, valvular and peripheral interventions and to see examples...
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial
27 Nov 2020
The ALPHEUS study sought to investigate whether more potent and rapid platelet inhibition properties of ticagrelor could reduce periprocedural atherothrombotic complications in chronic coronary syndrome patients undergoing high-risk PCI.
Reviewer
Tony Gershlick - A tribute from South Africa
24 Nov 2020
On behalf of the whole PCR Community, William Wijns and Jean Fajadet, Chairmen of PCR, extend their condolences upon the loss of Tony Gershlick. Read this tribute to an exceptional teacher and mentor in interventional cardiology by Farrel Hellig and David Kettles.
Author
Author
Best of #AHA20 Interventional Trials
19 Nov 2020
Mirvat Al Asnag provides reviews and take-home messages from a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2020 virtual edition of the American Heart Association Congress.
Author
